LD-2 disclosure · 1st Quarter - Report
MYRIAD GENETICS, INC.
via MYRIAD GENETICS, INC.
Client
- Name
- MYRIAD GENETICS, INC.
- Location
- District of Columbia · United States of America
Registrant
- Firm
- MYRIAD GENETICS, INC.
- Description
- Clinical laboratory
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesMedical/Disease Research/Clinical Labs
Regulation of laboratory developed tests - "Verifying Accurate, Leading-edge IVCT Development (VALID) Act" (HR 4128 / S 2209)
LobbyistsKIMBERLY LINTHICUM
Covered position (KIMBERLY LINTHICUM): Leg Director, Rep Bob Franks (1997-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996)
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations
FY23 House and Senate MilCon/VA appropriations; access to depression treatments for veterans
LobbyistsKIMBERLY LINTHICUM
Covered position (KIMBERLY LINTHICUM): Leg Director, Rep Bob Franks (1197-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996)
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Mental health legislation; no draft, no bill introduced - access to genetic testing for mental health treatment decisions Telehealth provisions following PHE; HR6202/S3593 - provisions requiring in person visits prior to ordering lab tests